1. Home
  2. RCKT vs OI Comparison

RCKT vs OI Comparison

Compare RCKT & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • OI
  • Stock Information
  • Founded
  • RCKT 1999
  • OI 1903
  • Country
  • RCKT United States
  • OI United States
  • Employees
  • RCKT N/A
  • OI N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • OI Containers/Packaging
  • Sector
  • RCKT Health Care
  • OI Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • OI Nasdaq
  • Market Cap
  • RCKT 1.6B
  • OI 2.0B
  • IPO Year
  • RCKT N/A
  • OI N/A
  • Fundamental
  • Price
  • RCKT $15.67
  • OI $12.77
  • Analyst Decision
  • RCKT Strong Buy
  • OI Buy
  • Analyst Count
  • RCKT 9
  • OI 8
  • Target Price
  • RCKT $53.22
  • OI $16.25
  • AVG Volume (30 Days)
  • RCKT 673.8K
  • OI 1.7M
  • Earning Date
  • RCKT 11-07-2024
  • OI 10-29-2024
  • Dividend Yield
  • RCKT N/A
  • OI N/A
  • EPS Growth
  • RCKT N/A
  • OI N/A
  • EPS
  • RCKT N/A
  • OI N/A
  • Revenue
  • RCKT N/A
  • OI $6,643,000,000.00
  • Revenue This Year
  • RCKT N/A
  • OI N/A
  • Revenue Next Year
  • RCKT $411.05
  • OI N/A
  • P/E Ratio
  • RCKT N/A
  • OI N/A
  • Revenue Growth
  • RCKT N/A
  • OI N/A
  • 52 Week Low
  • RCKT $15.72
  • OI $10.08
  • 52 Week High
  • RCKT $32.53
  • OI $17.58
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 36.28
  • OI 52.86
  • Support Level
  • RCKT $16.65
  • OI $11.07
  • Resistance Level
  • RCKT $17.83
  • OI $13.48
  • Average True Range (ATR)
  • RCKT 0.80
  • OI 0.46
  • MACD
  • RCKT -0.09
  • OI 0.13
  • Stochastic Oscillator
  • RCKT 0.79
  • OI 70.58

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: